Liu S, Labouebe G, Karunakaran S, Clee SM, Borgland SL
Brain Activation Studies Neuroanatomical studies using c-Fos immunoreactivity (a marker of neuronal activation) mapped PT-141s central effects: Activation concentrated in hypothalamic nuclei including mPOA, paraventricular nucleus, and arcuate nucleus Limbic system activation in regions processing reward and motivation Dose-dependent activation patterns correlating with behavioral responses Selective activation in regions known to control sexual function across species Clinical Translation Gap: Despite robust preclinical evidence and successful Phase 3 trials in women, PT-141 currently has FDA approval only for premenopausal women with HSDD
Just put it up there, write it up
Pharmacokinetic and clinical studies with levocarnitine have shown that administration of levocarnitine to ESRD patients on hemodialysis results in increased plasma levocarnitine concentrations
on training days, 30 minutes before exercise
This is a highly invasive solution reserved for when the joint is so severely damaged that nothing else has worked
